This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Brown & Brown (BRO) Unit Buyout to Enrich Service Portfolio
by Zacks Equity Research
Brown & Brown (BRO) arm buys Rodman Insurance, which is anticipated to add substance to the company's service portfolio via a comprehensive suite of P&C insurance products and services.
Willis Towers (WLTW) Beats on Q3 Earnings, Revises View
by Zacks Equity Research
Willis Towers (WLTW) Q3 reflects organic revenue growth as well as a consistent margin expansion.
Arthur J. Gallagher (AJG) Q3 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Solid organic growth, strong segmental performance and margin expansion drive Arthur J. Gallagher's (AJG) Q3 performance.
Arthur J. Gallagher (AJG) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 1.30% and 5.29%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Q3 Earnings Due on Oct 25: CINF, AJG & More
by Zacks Equity Research
Better investment results, premium rise and tax cut are likely to aid four insurance stocks in focus.
Insurance Brokerage Stock Outlook: Bumpy Ride Ahead
by Zacks Equity Research
Expenses related to investments in technology and analytics will keep the operating costs elevated. Higher debt levels, due to inorganic growth initiatives, can result in increased interest expenses.
Arthur J. Gallagher (AJG) Q3 Earnings: What's in Store?
by Zacks Equity Research
Stronger revenues and better-than-expected organic growth might aid Arthur J. Gallagher's (AJG) Q3. But rising expenses might be a drag.
Arthur J. Gallagher (AJG) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum Group Expands Base in Poland With Pramerica Buyout
by Zacks Equity Research
Unum Group's (UNM) acquisition of Pramerica will help widen its footprint in Poland as well as strengthen its financial protection offering.
Markel (MKL) to Acquire Brahmin Through Markel Venture
by Zacks Equity Research
Markel (MKL) lends a nod to buy Brahmin in tandem with its strategy to invest in profitable business beyond insurance via Markel Ventures.
Brown & Brown's Unit Buyout to Improve Service Portfolio
by Zacks Equity Research
Brown & Brown (BRO) arm buys Vandroff Insurance, which is anticipated to add value to its service portfolio while providing a combination of coverage, service and price.
Arthur J. Gallagher Consolidates Portfolio With Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Rogers & Young Insurance Services will help it solidify its portfolio of coverages to better serve clients in San Francisco and Oregon.
Arthur J. Gallagher's Buyout to Solidify California Foothold
by Zacks Equity Research
Arthur J. Gallagher (AJG) boosts its inorganic growth profile at a regular pace, this time with Wheatman Insurance buyout.
Arthur J. Gallagher's Acquisition to Brace Australian Base
by Zacks Equity Research
Arthur J. Gallagher (AJG) consistently drives its inorganic growth profile, this time with Super-Advice buyout.
Arthur J. Gallagher Gains 24% in a Year: What's Driving it?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) operating efficiency and growth initiatives help the stock continue its bull run.
Marsh & McLennan's Unit to Buy Summit and Pavilion
by Zacks Equity Research
Marsh & McLennan's (MMC) unit Mercer to buy Summit and Pavilion for its consulting business.
Arthur J. Gallagher's (AJG) Buyout to Solidify Canadian Base
by Zacks Equity Research
Arthur J. Gallagher (AJG) consistently ramps up its inorganic growth profile, the latest being the acquisition of Leystone Insurance.
Arthur J. Gallagher (AJG) Q2 Earnings In Line, Revenues Beat
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results show bottom-line improvement, organic growth, robust revenues and a solid segmental performance.
Insurance Stocks' Earnings Due on Jul 26: CINF, HIG & More
by Zacks Equity Research
Benign catastrophe loss, strong operating environment and a solid capital position favor insurers this earnings season.
Aon's (AON) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Aon (AON)'s second-quarter earnings is likely to benefit from its strategic investments and a better portfolio mix.
Can Higher Volumes Drive CME Group's (CME) Earnings in Q2?
by Zacks Equity Research
CME Group's (CME) second quarter is expected to be driven by improved volumes.
Can Nasdaq (NDAQ) Keep Earnings Beat Streak Alive in Q2?
by Zacks Equity Research
Nasdaq's (NDAQ) second quarter is likely to benefit from improvement in trading business.
Can Marsh & McLennan (MMC) Deliver a Beat in Q2 Earnings?
by Zacks Equity Research
Marsh & McLennan (MMC) is likely to ride high in Q2 on the back of robust revenues.
Arthur J. Gallagher (AJG) Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Higher revenues and better-than-expected organic growth might drive Arthur J. Gallagher's (AJG) Q2 earnings performance. However, rising expenses might be a dampener.
Brown & Brown's (BRO) Unit Buyout to Serve Clients Better
by Zacks Equity Research
Brown & Brown's (BRO) arm buys Professional Disability Associates, poised to add value to its service portfolio while serving its clients with more efficiency.